We analyze results on m-~scattering using a framework based on nonlinear chiral Lagrangians both at the tree level and at one-loop order. Overall the data can be well understood up to energies of 0.7-0.8 GeV, as well as at threshold, and some of the Lagrangian parameters are well determined. As a side comment, we note that the Skyrmion solution is stable given this experimental fourth-order Lagrangian, but its mass is about 70% too high.
The flaws and advantages of the different kinds of models for semileptonic b -u transitions are critically discussed. We argue that bound-state transition models are incomplete and should not be applied in phenomenological analyses of the electron end-point distribution. We describe a realistic model which corrects these deficiencies and combines the better features of the quark-decay models and the bound-state models.
In this paper, we study the Cabibbo favored non-leptonic D 0 decays into K − π + decays. First we show that, within the Standard Model, the corresponding CP asymmetry is strongly suppressed and out of the experimental range even taking into account the large strong phases coming from final state Interactions. We show also that although new physics models with extra sequential generation can enhance the CP asymmetry by few orders of magnitude however the resulting CP asymmetry is still far from experimental range. The most sensitive New Physics Models to this CP asymmetry comes from no-manifest Left-Right models where a CP asymmetry up to 10% can be reached and general two Higgs models extension of SM where a CP asymmetry of order 10 −2 can be obtained without being in contradiction with the experimental constraints on these models.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.